z-logo
open-access-imgOpen Access
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Author(s) -
Serdar Çelik,
Zekiye Altun,
Safiye Aktaş
Publication year - 2018
Publication title -
üroonkoloji bülteni
Language(s) - English
Resource type - Journals
eISSN - 2147-2122
pISSN - 2147-2270
DOI - 10.4274/uob.947
Subject(s) - pd l1 , ctla 4 , immunotherapy , cancer research , immune checkpoint , bladder cancer , nivolumab , medicine , cancer , immune system , immunology , t cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here